Profitect Wins Retailers’ Choice Award for Third Consecutive Year at RILA Retail Conference 2018
May 08, 2018 12:01 pm UTC| Business
BURLINGTON, Mass., May 08, 2018 -- Profitect Inc., the leading prescriptive analytics provider for the retail and CPG industry, today announced its third consecutive win of the Retailers’ Choice Award at the 2018 Retail...
May 08, 2018 12:01 pm UTC| Business
EDEN PRAIRIE, Minn., May 08, 2018 -- CHF Solutions, Inc. (Nasdaq:CHFS) announced today its results for the first quarter ended March 31, 2018, which included the following highlights: Revenue for first quarter ended...
NXT Energy Solutions Announces Release Date for Its 2018 First Quarter Results and Conference Call
May 08, 2018 12:01 pm UTC| Business
CALGARY, Alberta, May 08, 2018 -- NXT Energy Solutions Inc. (“NXT” or the "Company") (TSX:SFD) (OTC QB:NSFDF) announces it will release its first quarter financial and operating results for the quarter ended March 31,...
May 08, 2018 12:01 pm UTC| Business
NEW HAVEN, Conn., May 08, 2018 -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced...
Celsion Corporation to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference
May 08, 2018 12:01 pm UTC| Business
LAWRENCEVILLE, N.J., May 08, 2018 -- Celsion Corporation (NASDAQ: CLSN) announced today that Michael H. Tardugno, Chairman, President and Chief Executive Officer of Celsion, will present at the RHK Capital 2018...
Dataguise Now Certified on MapR Converged Data Platform 6.0
May 08, 2018 12:01 pm UTC| Business
FREMONT, Calif., May 08, 2018 -- Dataguise, a leader in data-centric audit and protection (DCAP), announced today that its DgSecure platform has been certified with version 6.0 of the MapR Converged Data Platform....
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 08, 2018 12:01 pm UTC| Business
AUSTIN, Texas, May 08, 2018 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases...